Investors reacted negatively to the news. The company’s stock fell more than 16% yesterday. It’s also a setback in ...

Vinay Prasad will be the next director of the FDA's Center for Biologics Evaluation and Research, after Peter Marks was ...

Google’s chief health officer Karen DeSalvo announced she will retire this summer. DeSalvo, who likes to introduce herself as ...

The pharmaceutical industry has long relied on a test that uses a protein called LAL taken from the blood of American ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

Americans are far too accepting of political control of health-related decisions when governments have no demonstrated ...

The Trump administration has asked a judge to toss out a lawsuit from three Republican-led states seeking to cut off ...

Federal agencies, including the FDA and the EPA, were ordered to accelerate approval of domestic manufacturing plants.

U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...

The NIH Clinical Center is struggling to carry out its mission of running clinical trials for the hardest-to-treat diseases ...

Vertex shares fell in after-hours trading, as investors considered a stock trading near its all-time high with a longer wait ...

Charles Lieber, the former chair of Harvard’s chemistry department who was convicted of lying to federal agents about his ...